WilliamGrobmanMD

Maternal & Fetal Medicine/High Risk

Professor in OB/GYN-Maternal Fetal Medicine, Northwestern University Medical School

Dr. Grobman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
101 Plain St
Fl 6
Providence, RI 02903
Phone+1 401-274-1122

Fax+1 401-453-7622

McGaw Medical Center of Northwestern UniversityFellowship, Maternal-Fetal Medicine, 1997 - 2000
McGaw Medical Center of Northwestern UniversityResidency, Obstetrics and Gynecology, 1993 - 1997
Harvard Medical SchoolClass of 1993

PubMed

72 citations
Elective induction of labor at 39 weeks compared with expectant management: a meta-analysis of cohort studies.
William A. Grobman, Aaron B. Caughey
American Journal of Obstetrics and Gynecology. 2019-02-25
130 citations
Trends in Gestational Diabetes at First Live Birth by Race and Ethnicity in the US, 2011-2019
Nilay S. Shah, Michael C. Wang, Priya M. Freaney, Amanda M. Perak, Mercedes R. Carnethon
JAMA. 2021-08-17
72 citations
Prediction of vaginal birth after cesarean delivery in term gestations: a calculator without race and ethnicity.
William A. Grobman, Grecio Sandoval, Madeline Murguia Rice, Jennifer L. Bailit, Suneet P. Chauhan
American Journal of Obstetrics and Gynecology. 2021-05-24

Journal Articles

888 Markers of Maternal Morbidity in Nulliparous Women
David M Haas, William A Grobman, Ronald J Wapner, Uma M Reddy, American Journal of Obstetrics and Gynecology
1072 Early Pregnancy BMI and Angiogenesis-Related Biomarkers (sFlt-1/PlGF): A Pathway for Adverse Pregnancy Outcomes?
William A Grobman, Uma M Reddy, Hyagriv Simhan, David M Haas, American Journal of Obstetrics and Gynecology
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm P...
Michael J Paidas, George A Macones, Garrett K Lam, Everett F Magann, Erika F Werner, Mounira A Habli, Chad A Grotegut, Sherri A Longo, Erol Amon, William A Grobman, De..., American Journal of Obstetrics and Gynecology
Effect of a Patient-Centered Decision Support Tool on Rates of Trial of Labor After Previous Cesarean Delivery
Anjali J Kaimal, Mari-Paule Thiet, Yamilee Bermingham, Anna L Altshuler, William A Grobman, JAMA
Association of Term Labor Induction vs Expectant Management with Child Academic Outcomes
Erika F Werner, William A Grobman, JAMA Network Open
Patterns of Leisure-Time Physical Activity Across Pregnancy and Adverse Pregnancy Outcomes
Hyagriv N Simhan, Deborah B Ehrenthal, William A Grobman, Judith H Chung, Philip Greenland, Anthony L Shanks, Samuel Parry, David M Haas, Ronald J Wapner, BioMed Central
Join now to see all

Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)August 2020
Effect of a Patient-Centered Decision Support Tool on Rates of Trial of Labor After Previous Cesarean DeliveryJune 2020
Effect of a Patient-Centered Decision Support Tool on Rates of Trial of Labor After Previous Cesarean DeliveryJune 2020
Health Resource Utilization of Labor Induction Versus Expectant ManagementJanuary 2020
Opioid Prescribing Patterns Among Postpartum WomenApril 2018
Associations of Neighborhood-Level Racial Residential Segregation with Adverse Pregnancy OutcomesFebruary 2018
Join now to see all

Does Risk for Heart Disease Start Before Birth?February 13th, 2023
Gen Z and Millennials Twice as Likely to Develop Hypertension in PregnancySeptember 6th, 2022
American Heart Association Awards $20 Million for Research to Improve Outcomes in Pregnancy, CVD HealthJuly 12th, 2022
Join now to see all